Cargando…
Malawian children with fast-breathing pneumonia with and without comorbidities
BACKGROUND: Due to high risk of mortality, children with comorbidities are typically excluded from trials evaluating pneumonia treatment. Understanding heterogeneity of outcomes among children with pneumonia and comorbidities is critical to ensuring appropriate treatment. METHODS: We explored whethe...
Autores principales: | Ginsburg, Amy Sarah, Mvalo, Tisungane, Hwang, Jun, Phiri, Melda, McCollum, Eric D., Maliwichi, Madalitso, Schmicker, Robert, Phiri, Ajib, Lufesi, Norman, May, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905626/ https://www.ncbi.nlm.nih.gov/pubmed/33627192 http://dx.doi.org/10.1186/s41479-021-00081-y |
Ejemplares similares
-
Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021) -
Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian
children
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020) -
Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018) -
Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi
por: Nkwopara, Evangelyn, et al.
Publicado: (2019) -
Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
por: Ginsburg, Amy Sarah, et al.
Publicado: (2019)